Nalidixic acid

Nalidixic acid is a monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively. An orally administered antibacterial, it is used to treat lower urinary-tract infections due to Gram-negative bacteria, including the majority of E. coli, Enterobacter, Klebsiella, and Proteus species. Among its listed roles, it functions as a antibacterial drug, a DNA synthesis inhibitor and an antimicrobial agent. It is a monocarboxylic acid, a 1,8-naphthyridine derivative and a quinolone antibiotic. It is the conjugate acid of nalidixic acid anion. It is grouped under the following drug class(es): Quinolones and Topoisomerase inhibitors. Its therapeutic use is listed as antibiotics. The directory classifies it as a discontinued API with a semi-synthetic source/manufacturing origin. Other names for this substance include Nevigramon, Nalidixin and NegGram. Its PubChem CID is 4421.

CAS No 389-08-2
Molecular Formula C12H12N2O3
Molecular Weight 232.23 g/mol
Synonyms 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid

Frequently Asked Questions